According to the Securities Star data Center, Huaxi Biological 2021 reported that the company's main income was 1.937 billion yuan, up 104.44% from the same period last year; the net profit from its parent was 361 million yuan, up 35.01% from the same period last year; deducting 306 million yuan from non-net profit, up 30.68% from the same period last year; debt ratio 20.03%, investment income 21.2031 million yuan, financial expenses 4.0533 million yuan, gross profit margin 77.91%.
There are three new shareholders in this period. J.P. SecuritiesPLC--owned funds hold 804211 shares, accounting for 0.86% of tradable shares. J.P. Morgan own funds hold 804211 shares, accounting for 0.86% of tradable shares. China Industrial and Commercial Bank of China Co., Ltd.-Yi Fangda Shanghai Securities Chuangban 50-component trading index securities investment fund holds 904351 shares, accounting for 0.97% of tradable shares. A total of 6 shareholders reduced their holdings, JPMORGAN CHASE BANK,NATIONAL ASSOCIATION reduced its holdings by 2.153336 million shares, accounting for 5.66% of the outstanding shares, Ningxia win Rui Wuyuan Equity Investment Partnership (limited partnership) reduced its holdings by 6.338694 million shares, and the shareholder's shareholdings accounted for 19.4% of the tradable shares. China Industrial and Commercial Bank of China Co., Ltd.-Shenwanling Xinshengli selected Securities Investment Fund reduced its holdings by 204243 shares. The shareholder's shareholding accounted for 0.85% of the tradable shares, the National Social Security Fund 118 portfolio reduced its holdings by 50000 shares, the shareholder's shareholdings accounted for 4.34% of the tradable shares, and Bank of Communications-Huaxia Blue Chip Core Hybrid Securities Investment Fund (LOF) reduced its holdings by 110964 shares, accounting for 0.96% of the tradable shares. China Merchants Bank Co., Ltd.-Huaxia Shanghai Kechuang Board 50 component trading index securities investment fund reduced its holdings by 597334 shares, accounting for 1.61% of the outstanding shares.
For a summary of the financial report data, please see the following figure: